Friday, February 17, 2017 9:02:58 AM
From looking at Rehband, I agree, they are two similar companies-although one got its start in Sweden where the number of Crossfit affiliate gyms are in the lows 100's, and the other is getting its start in the U.S. where there are over 6,000 Crossfit affiliate gyms...meaning EXO will have easier access to more customers right off the bat Crossfit Affiliate Map
Looking at Rehband products I can already see that EXO is focusing more on using different colorways and interesting patterns to differentiate themselves. I think this is to their benefit. As someone who knows the Crossfit world myself, I know that everybody who does Crossfit wants to have their own "style" and "look" and they do this by wearing (sometimes ridiculous) gear and clothing...EXO appeals directly to this whereas Rehband seem less flashy...for example, EXO's new weightbelts are checkered/tropical while Rehband's are just black
It goes to show that there are many more areas EXO can expand into with future products such as compression shirts, arm sleeves, compression belts, shoulder sleeves, etc. and with endless patterns and color ways to make themselves stand out
MOST IMPORTANTLY IMO is the potential for EXO to fully-acquire their PR Manager's patent pending "Chestee" product which would give EXO something that no other company has!
Very happy to have found EXOL at its bottom
Recent SNPW News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 04/01/2024 09:04:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 10:15:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:30:36 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 10/23/2023 09:15:31 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 10/13/2023 09:00:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:06:10 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM